Diabetic foot is one of the main complications of diabetes mellitus; however, in hospitals of provinces from Perú, the relationship of this condition with hospital stay has not been calculated. Objective: To determine the association between hospitalization time and diabetic foot in three hospitals from Cusco, Perú. Methods: A cross-sectional study of secondary data analysis was conducted. We analyzed the data of patients with type 2 diabetes mellitus admitted to the internal medicine service between January and December 2016, in three tertiary hospitals in Cusco, Peru. Correlation coefficients and p-values were calculated using generalized linear models, with Gaussian family and identity function, adjusted by intervening variables. Values of p < 0.05 were considered statistically significant. Results: Of the 153 patients, 14% (21) had a diabetic foot diagnosis, and their median age wa...

Diabetic foot is one of the main complications of diabetes mellitus; however, in hospitals of provinces from Perú, the relationship of this condition with hospital stay has not been calculated. Objective: To determine the association between hospitalization time and diabetic foot in three hospitals from Cusco, Perú. Methods: A cross-sectional study of secondary data analysis was conducted. We analyzed the data of patients with type 2 diabetes mellitus admitted to the internal medicine service between January and December 2016, in three tertiary hospitals in Cusco, Peru. Correlation coefficients and p-values were calculated using generalized linear models, with Gaussian family and identity function, adjusted by intervening variables. Values of p < 0.05 were considered statistically significant. Results: Of the 153 patients, 14% (21) had a diabetic foot diagnosis, and their median age wa...

Introduction: The incidence of thyroid cancer has increased worldwide. Peru has few reports describing the national and regional epidemiology of thyroid cancer. Objective: The incidence of thyroid cancer has increased worldwide. Peru has few reports describing the national and regional epidemiology of thyroid cancer. Methods: A descriptive study of trends was conducted with secondary data obtained from a public information source in Peru. The ICD 10: C73.0 coding record was evaluated, by age group, year and region. The age-standardized prevalence (period 2005 to 2016) and mortality (period 2005 to 2015) were calculated by region and year of study. Results: In the 2005-2016 period, 19 513 cases of thyroid cancer were recorded. The age group with the highest frequency was 30 to 59 years (57.7%). The prevalence increased from 4.7 to 15.2 cases per 100 000 inhabitants in the period 2005-2016...

Introduction: The incidence of thyroid cancer has increased worldwide. Peru has few reports describing the national and regional epidemiology of thyroid cancer. Objective: The incidence of thyroid cancer has increased worldwide. Peru has few reports describing the national and regional epidemiology of thyroid cancer. Methods: A descriptive study of trends was conducted with secondary data obtained from a public information source in Peru. The ICD 10: C73.0 coding record was evaluated, by age group, year and region. The age-standardized prevalence (period 2005 to 2016) and mortality (period 2005 to 2015) were calculated by region and year of study. Results: In the 2005-2016 period, 19 513 cases of thyroid cancer were recorded. The age group with the highest frequency was 30 to 59 years (57.7%). The prevalence increased from 4.7 to 15.2 cases per 100 000 inhabitants in the period 2005-2016...

Introduction: The incidence of thyroid cancer has increased worldwide. Peru has few reports describing the national and regional epidemiology of thyroid cancer. Objective: The incidence of thyroid cancer has increased worldwide. Peru has few reports describing the national and regional epidemiology of thyroid cancer. Methods: A descriptive study of trends was conducted with secondary data obtained from a public information source in Peru. The ICD 10: C73.0 coding record was evaluated, by age group, year and region. The age-standardized prevalence (period 2005 to 2016) and mortality (period 2005 to 2015) were calculated by region and year of study. Results: In the 2005-2016 period, 19 513 cases of thyroid cancer were recorded. The age group with the highest frequency was 30 to 59 years (57.7%). The prevalence increased from 4.7 to 15.2 cases per 100 000 inhabitants in the period 2005-2016...